Invicta Diagnostic Limited – IPO
Invicta Diagnostic Limited – IPO Details
| IPO Date | December 1, 2025 to December 3, 2025 |
| Listing Date | December 8, 2025 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 80 to ₹ 85 / Share |
| Lot Size | 1600 Shares |
| Total Issue Size | 33,08,800 shares (Aggregating up to ₹28.12 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share holding pre issue | 92,63,173 shares |
| Share holding post issue | 1,25,71,973 shares |
| Market Maker portion |
Invicta Diagnostic Limited Timeline (Tentative Schedule)
Invicta Diagnostic Limited IPO opens on December 1, 2025, and closes on December 3, 2025.
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Basis of Allotment | December 4, 2025 |
| Initiation of Refunds | December 5, 2025 |
| Credit of Shares to Demat | December 5, 2025 |
| Listing Date | December 8, 2025 |
| Cut-off time for UPI mandate confirmation | December 3, 2025 |
Invicta Diagnostic Limited IPO Lot Size
Investors can bid for a minimum of 3,200 shares and in multiples of 1,600 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 3,200 | Rs.272,000 |
| Retail (Max) | 2 | 3,200 | Rs.272,000 |
| S-HNI (Min) | 3 | 4,800 | Rs.408,000 |
| S-HNI (Max) | 7 | 11,200 | Rs.952,000 |
| B-HNI (Min) | 8 | 12,800 | Rs.1,088,000 |
| HNI (Min) |
Invicta Diagnostic Limited IPO Promoter Holding
| Share Holding Pre Issue | 90.52% |
| Share Holding Post Issue |
Invicta Diagnostic Limited IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not more than 50% |
|
| NII (HNI) Shares Offered | Not less than 15% |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not less than 35% |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Invicta Diagnostic Limited IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Invicta Diagnostic Limited
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
- A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (CT, MRI)
- Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic services
- Three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (PET CT, X-ray, ultrasound) and sample collection.
The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.
Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:
- Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
- Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
- Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.
As of October 31, 2025, the company employed 157 permanent employees.
Competitive Strength:
- Expanding presence in the Mumbai Metropolitan Region (“MMR”), specifically in the radiology sector;
- A diagnostics provider that offers a one-stop solution at an affordable price;
- Technical capability and technology with IT infrastructure;
- Dedicated management team with significant industry experience; and
- Implementation of the Hub and Spoke Model.
Key Performance Indicator
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 44.28% |
| ROCE | 42.00% |
| Debt/Equity | 0.26 |
| RoNW | 36.25% |
| P/BV | 5.26 |
| PAT Margin (%) | 16.38% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 5.32 | 6.50 |
| P/E (x) | 15.97 | 13.08 |
Note:
- The Pre IPO EPS is calculated based on Pre-IPO shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, which is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2025, which is available in RHP.
Objects of the Issue (Invicta Diagnostic Limited IPO Objectives)
Invicta Diagnostic Limited Contact Details
Invicta Diagnostic Ltd. 1 GF, Plot 217, Ambavat Bhavan N.M Joshi Marg Delisle Road Mumbai, Maharashtra, 400013 Phone: 022 - 4971 0036 Email: [email protected] Website: https://www.pcdiagnostics.in/ |
Invicta Diagnostic Limited IPO Registrar
Bigshare Services Pvt.Ltd. Phone: +91-22-6263 8200 Email: [email protected] |